3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform3189companies in the directory 652ISIN verified against the check digit 7exchanges 14sectors No real-time quotes — a reference work, not a trading platform
DE · EN Newsletter
Biotech & Pharma Symbolbild · KI-generiert
Biotech & Pharma APPT

Apptly Health Technologies Corp.

APPT CSE Biotech & Pharma

Stock factsheet

TickerAPPT
ExchangeCSE
ISIN
WKN
SectorBiotech & Pharma
Size class Nano Cap
Market capitalisation 6 Mio. USD As of 2026-08-04

Company data from public sources (TMX Money, Canadian Securities Exchange, Nasdaq screener, Wikidata); every ISIN is verified against its check digit. Where „—“ appears, no verified value exists — we do not publish unverified identifiers. Market capitalisation is an order of magnitude as of the date shown, not a real-time figure. The size class follows the thresholds in common use (micro < $300m, small < $2bn, mid < $10bn) and is meant as an indication, not a definition.

Company profile

Apptly Health Technologies Corp. specializes in health technology ventures that enhance access to care, with a particular emphasis on site-of-care optimization and value-based service delivery. The Company’s flagship asset is an innovative healthcare marketplace connecting patients with top physicians with no referral, no insurance barriers, and no hidden costs. With more than 5,000 specialist physicians and clinicians across 55 specialties in the U.S., the Company empowers patients to access care quickly and affordably while giving doctors greater control over their time, revenue, and practice growth.

Company description as published by the issuer via Canadian Securities Exchange.

Comparable companies

Companies in the Biotech & Pharma sector of a similar size.

CompanyTickerExchangeMarket cap
Apptly Health Technologies Corp.APPT CSE6 Mio. USD
COSCIENS Biopharma Inc. CSCITSX 5 Mio. USD
WestBond Enterprises Corporation WBETSXV 5 Mio. USD
Avricore Health Inc. AVCRTSXV 5 Mio. USD
PreveCeutical Medical Inc. PREVCSE 7 Mio. USD
LIR Life Sciences Corp. SKNYCSE 7 Mio. USD
Marvel Biosciences Corp. MRVLTSXV 7 Mio. USD

Investor Relations

Annual reports Not recorded yet
Investor presentation Not recorded yet
Analyst coverage Not recorded yet

We link only to primary sources from the company itself and from the regulators. Fields we have not recorded stay empty until a reliable source is available.

Information and education only — not investment advice, not a recommendation and not a financial analysis within the meaning of §85 WpHG or Art. 20 MAR. Investments in small and micro caps are highly speculative; total loss is possible. All information without warranty.